Fig. S3 from The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing <i>NOTCH1</i> Expression and Targeting Tumor-Initiating Cells

Abstract

&lt;p&gt;Supplementary Fig S3. CBL0137 inhibits FACT function in SCLC TICs. A, SSRP1 levels were determined by Western analysis in CD133high or CD133low cells from H82 or H526. β-actin was used as a loading control. B, H82 CD133high cells were treated with 1 µM CBL0137 for different times. Soluble and chromatin bound SSRP1 levels were detected by immunoblotting.&lt;/p&gt;